Back to search

Article

Discovering and targeting dynamic drugging pockets of the oncogene KRAS-G12D

2022-07-02

Abstract excerpt

Activated KRAS-G12D mutations are the one of most frequent oncogenic drivers in human cancers. Unfortunately, no therapeutic agent directly targeting KRAS-G12D has been clinically approved yet, with such mutated species remaining undrugged. Notably, cofactor Mg 2+ is closely related to the function of small GTPases, but no investigation has been done yet on Mg 2+ when associated with KRAS. Herein, through micros...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
79a53ee9-8432-5075-b81b-a44aa6a8b8df
DOI
10.1101/2022.07.01.498403
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Discovering and targeting dynamic drugging pockets of the oncogene KRAS-G12DDOI 10.1101/2022.07.01.498403
Select a neighboring publication to make it the new centre.